Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...
Woman's World on MSN
Your doctor found colon polyps - now what? When to worry and next steps
After the fasting, the uncomfortable cleanse and a drowsy ride home, it's a relief to have your colonoscopy screening behind ...
In low-resource regions such as Nigeria, most people with colorectal cancer are diagnosed too late for curative treatment ...
Recursion Pharmaceuticals, Inc. upgraded to Buy on promising REC-4881 data, strong partnerships, and AI-driven drug discovery ...
“The research that’s needed most is the risk stratification research—who do we screen,” says Dr. Gabre. By getting to the ...
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median ...
Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...
SALT LAKE CITY, Dec. 08, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a clinical-stage TechBio company decoding biology to radically improve lives, today announced positive Phase 1b/2 data from ...
eRapa is a proprietary oral capsule formulation of rapamycin, also known as sirolimus. Rapamycin is an mTOR (mammalian Target Of Rapamycin) inhibitor. mTOR has been shown to have a significant role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results